Pitvarfibrilláció: vizsgálatok itt: Lettország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Daugavpils, Liepaja, Ogre, Riga, Valmiera
- Életkor
- 18 év and over
- People
- 15 364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - 3. fázisTaking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Daugavpils, Liepaja, Riga
- Életkor
- 18 év and over
- People
- 2628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - 3. fázisTaking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Daugavpils, Riga, Siguldas Pagasts, Valmiera
- Életkor
- 65 év and over
- People
- 2500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseTaking peopleObservation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
- Where
- Riga
- Életkor
- 18 év and over
- People
- 1400 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT04075084 - 4. fázisNot yet taking people in LettországAn open-label, randomized clinical trial comparing Etacizin versus Propafenone in Atrial Fibrillation
- Where
- Riga
- Életkor
- 18 év and over
- People
- 30
- Run by
- Olpha AS
See details and how to join2025-521267-13-01 · EU 2025-521267-13-01